-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$60.00-27.54% Downside
Belite Bio, Inc Frequently Asked Questions
-
What analysts cover Belite Bio, Inc?
Belite Bio, Inc has been rated by research analysts at H.C. Wainwright in the past 90 days.